Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/19659999

Download in:

View as

General Info

PMID
19659999